The aim of this project is to manufacture, in France, a cell therapy product from pluripotent stem cells for the... View Article
Author Archives for Adeline Chauvigné
France Relance | GoLiver Therapeutics awarded a grant of 1 M€ to produce regenerative cells
14 May 2025The aim of this project is to manufacture, in France, a cell therapy product from pluripotent stem cells for the... View Article
Valneva Joins Euronext SBF 120 and CAC Mid 60 Indices
Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant... View Article
Valneva Joins Euronext SBF 120 and CAC Mid 60 Indices
14 May 2025Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant... View Article
New member | Althenas
Althenas supports AI & health projects of public and private organizations, from consulting advice to complete project management. The company... View Article
New member | Althenas
14 May 2025Althenas supports AI & health projects of public and private organizations, from consulting advice to complete project management. The company... View Article
OSE Immunotherapeutics and ARCAGY – GINECO Announce Initiation of a Randomized Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Pembrolizumab in Ovarian Cancer
This clinical trial will be sponsored and conducted by the French oncology cooperative group ARCAGY-GINECO and supported by Merck Sharp... View Article
OSE Immunotherapeutics and ARCAGY – GINECO Announce Initiation of a Randomized Phase 2 Clinical Trial Evaluating Tedopi® in Combination with Pembrolizumab in Ovarian Cancer
14 May 2025This clinical trial will be sponsored and conducted by the French oncology cooperative group ARCAGY-GINECO and supported by Merck Sharp... View Article
New member | Orthopus
ORTHOPUS designs open-source technical aids for physical disabilities at fair prices. Based in Nantes, this company develops two ranges of... View Article
New member | Orthopus
14 May 2025ORTHOPUS designs open-source technical aids for physical disabilities at fair prices. Based in Nantes, this company develops two ranges of... View Article
Valneva and Pfizer announce initiation of phase 2 study for Lyme disease vaccine candidate
The Phase 2 study will include both adult and pediatric subjects with an aim to support acceleration of the vaccine... View Article
Valneva and Pfizer announce initiation of phase 2 study for Lyme disease vaccine candidate
14 May 2025The Phase 2 study will include both adult and pediatric subjects with an aim to support acceleration of the vaccine... View Article
The European Patent Office has granted McSAF a patent for DAR 4 antibody-drug conjugates technology
The European Patent Office (EPO) has granted the patent number EP3521314 on the McSAF Inside® technology to access DAR 4... View Article
The European Patent Office has granted McSAF a patent for DAR 4 antibody-drug conjugates technology
14 May 2025The European Patent Office (EPO) has granted the patent number EP3521314 on the McSAF Inside® technology to access DAR 4... View Article
Valneva initiates phase 3 clinical lot consistency study for its single-shot chikungunya vaccine candidate
Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need, today announced that... View Article
Valneva initiates phase 3 clinical lot consistency study for its single-shot chikungunya vaccine candidate
14 May 2025Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need, today announced that... View Article
New member | Parean Biotechnologies
Parean Biotechnologies is an European expert of deep immune phenotyping, and multi-omics data analysis. With co-founders know-how, built in academic... View Article
New member | Parean Biotechnologies
14 May 2025Parean Biotechnologies is an European expert of deep immune phenotyping, and multi-omics data analysis. With co-founders know-how, built in academic... View Article
Pherecydes Pharma is adding to its patent portfolio with two new patents granted in the United States
Pherecydes Pharma, a biotechnology company specialized in precision phagotherapy designed to fight resistant and/or complex bacterial infections, recently announced the... View Article
Pherecydes Pharma is adding to its patent portfolio with two new patents granted in the United States
14 May 2025Pherecydes Pharma, a biotechnology company specialized in precision phagotherapy designed to fight resistant and/or complex bacterial infections, recently announced the... View Article